JPS58220696A - グルタメ−ト−オキサロアセテ−ト−トランスアミナ−ゼの活性測定法及びそのための分析試薬及び分析試験片 - Google Patents
グルタメ−ト−オキサロアセテ−ト−トランスアミナ−ゼの活性測定法及びそのための分析試薬及び分析試験片Info
- Publication number
- JPS58220696A JPS58220696A JP58097034A JP9703483A JPS58220696A JP S58220696 A JPS58220696 A JP S58220696A JP 58097034 A JP58097034 A JP 58097034A JP 9703483 A JP9703483 A JP 9703483A JP S58220696 A JPS58220696 A JP S58220696A
- Authority
- JP
- Japan
- Prior art keywords
- mmol
- glutamate
- activity
- chromogen
- imidazole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000000694 effects Effects 0.000 title claims abstract description 22
- 238000012360 testing method Methods 0.000 title claims description 27
- 238000005259 measurement Methods 0.000 title claims description 26
- 239000003153 chemical reaction reagent Substances 0.000 title claims description 16
- 238000000034 method Methods 0.000 claims abstract description 26
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Substances C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims abstract description 10
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims abstract description 9
- 102000003992 Peroxidases Human genes 0.000 claims abstract description 9
- 108040007629 peroxidase activity proteins Proteins 0.000 claims abstract description 9
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 8
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 claims abstract description 7
- 108010042687 Pyruvate Oxidase Proteins 0.000 claims abstract description 7
- 229930195712 glutamate Natural products 0.000 claims abstract description 7
- 229910019142 PO4 Inorganic materials 0.000 claims abstract description 6
- 239000010452 phosphate Substances 0.000 claims abstract description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims abstract description 6
- 239000000126 substance Substances 0.000 claims abstract description 6
- 239000000872 buffer Substances 0.000 claims abstract description 5
- LIPOUNRJVLNBCD-UHFFFAOYSA-N acetyl dihydrogen phosphate Chemical compound CC(=O)OP(O)(O)=O LIPOUNRJVLNBCD-UHFFFAOYSA-N 0.000 claims abstract description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 3
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 3
- 239000001301 oxygen Substances 0.000 claims abstract description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims abstract 4
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 claims abstract 4
- 239000007864 aqueous solution Substances 0.000 claims abstract 2
- 239000001569 carbon dioxide Substances 0.000 claims abstract 2
- 229910002092 carbon dioxide Inorganic materials 0.000 claims abstract 2
- 238000006243 chemical reaction Methods 0.000 claims description 32
- 102000004190 Enzymes Human genes 0.000 claims description 15
- 108090000790 Enzymes Proteins 0.000 claims description 15
- ADVPTQAUNPRNPO-UHFFFAOYSA-N 2-azaniumyl-3-sulfinopropanoate Chemical compound OC(=O)C(N)CS(O)=O ADVPTQAUNPRNPO-UHFFFAOYSA-N 0.000 claims description 11
- VWWQXMAJTJZDQX-UYBVJOGSSA-N flavin adenine dinucleotide Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1CO[P@](O)(=O)O[P@@](O)(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C2=NC(=O)NC(=O)C2=NC2=C1C=C(C)C(C)=C2 VWWQXMAJTJZDQX-UYBVJOGSSA-N 0.000 claims description 9
- 235000019162 flavin adenine dinucleotide Nutrition 0.000 claims description 9
- 239000011714 flavin adenine dinucleotide Substances 0.000 claims description 9
- 229940093632 flavin-adenine dinucleotide Drugs 0.000 claims description 9
- 102000003929 Transaminases Human genes 0.000 claims description 8
- 108090000340 Transaminases Proteins 0.000 claims description 8
- 239000000243 solution Substances 0.000 claims description 7
- 229960002363 thiamine pyrophosphate Drugs 0.000 claims description 7
- 235000008170 thiamine pyrophosphate Nutrition 0.000 claims description 7
- 239000011678 thiamine pyrophosphate Substances 0.000 claims description 7
- YXVCLPJQTZXJLH-UHFFFAOYSA-N thiamine(1+) diphosphate chloride Chemical compound [Cl-].CC1=C(CCOP(O)(=O)OP(O)(O)=O)SC=[N+]1CC1=CN=C(C)N=C1N YXVCLPJQTZXJLH-UHFFFAOYSA-N 0.000 claims description 7
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 6
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N Aminoantipyrine Natural products CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 claims description 5
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 claims description 4
- 230000003197 catalytic effect Effects 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 239000002250 absorbent Substances 0.000 claims description 3
- 230000002745 absorbent Effects 0.000 claims description 3
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 3
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 3
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 3
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 claims description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 2
- 239000007995 HEPES buffer Substances 0.000 claims description 2
- 102000013009 Pyruvate Kinase Human genes 0.000 claims description 2
- 108020005115 Pyruvate Kinase Proteins 0.000 claims description 2
- 159000000003 magnesium salts Chemical class 0.000 claims 3
- 239000007788 liquid Substances 0.000 claims 2
- 229940053326 magnesium salt Drugs 0.000 claims 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 1
- 235000004279 alanine Nutrition 0.000 claims 1
- 238000004458 analytical method Methods 0.000 claims 1
- 230000005540 biological transmission Effects 0.000 claims 1
- 239000007853 buffer solution Substances 0.000 claims 1
- 239000006172 buffering agent Substances 0.000 claims 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 claims 1
- 229960001484 edetic acid Drugs 0.000 claims 1
- 229940005657 pyrophosphoric acid Drugs 0.000 claims 1
- IWOKCMBOJXYDEE-UHFFFAOYSA-N sulfinylmethane Chemical compound C=S=O IWOKCMBOJXYDEE-UHFFFAOYSA-N 0.000 claims 1
- 239000000975 dye Substances 0.000 abstract description 8
- 239000002253 acid Substances 0.000 abstract description 4
- KPGXRSRHYNQIFN-UHFFFAOYSA-L 2-oxoglutarate(2-) Chemical compound [O-]C(=O)CCC(=O)C([O-])=O KPGXRSRHYNQIFN-UHFFFAOYSA-L 0.000 abstract description 3
- 239000003795 chemical substances by application Substances 0.000 abstract description 3
- SZXKSDXHODZTFS-UHFFFAOYSA-N 4-[4,5-bis[4-(dimethylamino)phenyl]-1H-imidazol-2-yl]-2,6-dimethoxyphenol Chemical compound COC1=C(O)C(OC)=CC(C=2NC(=C(N=2)C=2C=CC(=CC=2)N(C)C)C=2C=CC(=CC=2)N(C)C)=C1 SZXKSDXHODZTFS-UHFFFAOYSA-N 0.000 abstract 2
- 239000004291 sulphur dioxide Substances 0.000 abstract 1
- 235000010269 sulphur dioxide Nutrition 0.000 abstract 1
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 12
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 11
- KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 150000007857 hydrazones Chemical class 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 238000011534 incubation Methods 0.000 description 5
- 210000002381 plasma Anatomy 0.000 description 5
- 238000002835 absorbance Methods 0.000 description 4
- 239000012085 test solution Substances 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 3
- 239000003365 glass fiber Substances 0.000 description 3
- SXGZJKUKBWWHRA-UHFFFAOYSA-N 2-(N-morpholiniumyl)ethanesulfonate Chemical compound [O-]S(=O)(=O)CC[NH+]1CCOCC1 SXGZJKUKBWWHRA-UHFFFAOYSA-N 0.000 description 2
- -1 Dinitrophenyl Chemical group 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- WMFYOYKPJLRMJI-UHFFFAOYSA-N Lercanidipine hydrochloride Chemical compound Cl.COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(C=2C=CC=CC=2)C=2C=CC=CC=2)C1C1=CC=CC([N+]([O-])=O)=C1 WMFYOYKPJLRMJI-UHFFFAOYSA-N 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000012954 diazonium Substances 0.000 description 2
- 150000001989 diazonium salts Chemical class 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 2
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 2
- GHPYJLCQYMAXGG-WCCKRBBISA-N (2R)-2-amino-3-(2-boronoethylsulfanyl)propanoic acid hydrochloride Chemical compound Cl.N[C@@H](CSCCB(O)O)C(O)=O GHPYJLCQYMAXGG-WCCKRBBISA-N 0.000 description 1
- CNEQMTSMAJPKCH-UHFFFAOYSA-N (sulfinoamino)benzene Chemical compound OS(=O)NC1=CC=CC=C1 CNEQMTSMAJPKCH-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000029578 Muscle disease Diseases 0.000 description 1
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 1
- AFBPFSWMIHJQDM-UHFFFAOYSA-N N-methylaniline Chemical compound CNC1=CC=CC=C1 AFBPFSWMIHJQDM-UHFFFAOYSA-N 0.000 description 1
- 101150003018 Patj gene Proteins 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- WDJHALXBUFZDSR-UHFFFAOYSA-M acetoacetate Chemical compound CC(=O)CC([O-])=O WDJHALXBUFZDSR-UHFFFAOYSA-M 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 150000001448 anilines Chemical class 0.000 description 1
- 239000000987 azo dye Substances 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 125000001072 heteroaryl group Chemical group 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 239000012434 nucleophilic reagent Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000005691 oxidative coupling reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 150000004728 pyruvic acid derivatives Chemical class 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
- C12Q1/52—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving transaminase
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/805—Test papers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19823221730 DE3221730A1 (de) | 1982-06-09 | 1982-06-09 | Verfahren und analytische mittel zur aktivitaetsbestimmung von glutamat-oxalacetat-transaminase |
| DE3221730.7 | 1982-06-09 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS58220696A true JPS58220696A (ja) | 1983-12-22 |
| JPH0368679B2 JPH0368679B2 (cg-RX-API-DMAC7.html) | 1991-10-29 |
Family
ID=6165690
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58097034A Granted JPS58220696A (ja) | 1982-06-09 | 1983-06-02 | グルタメ−ト−オキサロアセテ−ト−トランスアミナ−ゼの活性測定法及びそのための分析試薬及び分析試験片 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4591553A (cg-RX-API-DMAC7.html) |
| EP (1) | EP0100413B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JPS58220696A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE17872T1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA1206401A (cg-RX-API-DMAC7.html) |
| DD (1) | DD209848A5 (cg-RX-API-DMAC7.html) |
| DE (2) | DE3221730A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES8402877A1 (cg-RX-API-DMAC7.html) |
| IE (1) | IE55265B1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA834166B (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5834226A (en) * | 1991-01-31 | 1998-11-10 | Xytronyx, Inc. | One-step test for aspartate aminotransferase |
| US5859113A (en) | 1997-07-17 | 1999-01-12 | E. I. Du Pont De Nemours And Company | Pigment dispersions containing hydroxylated AB-block polymer dispersant |
| CN102288747B (zh) * | 2011-08-19 | 2013-11-27 | 长沙三诺生物传感技术股份有限公司 | 去除干扰的干化学定量测试试条、谷丙或谷草转氨酶定量测试试条及检测方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3701601A (en) * | 1968-03-04 | 1972-10-31 | Sherwood Medical Ind Inc | Photometric read out and analyzing system |
| US3875014A (en) * | 1973-12-14 | 1975-04-01 | American Cyanamid Co | Glutamic oxaloacetic transaminase test material |
| US4089747A (en) * | 1976-08-09 | 1978-05-16 | Eastman Kodak Company | Compositions for the detection of hydrogen peroxide |
| US4184923A (en) * | 1977-11-03 | 1980-01-22 | Eastman Kodak Company | Reduction of gentisic acid interference in analytical elements |
| US4246342A (en) * | 1978-03-25 | 1981-01-20 | Toyo Jozo Kabushiki Kaisha | Process for the manufacture of pyruvate oxidase, and analytical method and kit for the use of the same |
| DE2834706A1 (de) * | 1978-08-08 | 1980-02-14 | Boehringer Mannheim Gmbh | Verfahren und reagens zur bestimmung von glutamat-oxalacetat-transaminase und glutamat-pyruvat-transaminase |
| IT1162349B (it) * | 1979-07-17 | 1987-03-25 | Biodata Spa | Metodo per la determinazione delle transaminasi e relativo kit diagnostico |
-
1982
- 1982-06-09 DE DE19823221730 patent/DE3221730A1/de not_active Withdrawn
-
1983
- 1983-06-01 US US06/500,111 patent/US4591553A/en not_active Expired - Lifetime
- 1983-06-02 JP JP58097034A patent/JPS58220696A/ja active Granted
- 1983-06-03 EP EP83105503A patent/EP0100413B1/de not_active Expired
- 1983-06-03 AT AT83105503T patent/ATE17872T1/de not_active IP Right Cessation
- 1983-06-03 DE DE8383105503T patent/DE3362076D1/de not_active Expired
- 1983-06-07 DD DD83251806A patent/DD209848A5/de not_active IP Right Cessation
- 1983-06-08 IE IE1351/83A patent/IE55265B1/en not_active IP Right Cessation
- 1983-06-08 ZA ZA834166A patent/ZA834166B/xx unknown
- 1983-06-08 CA CA000429972A patent/CA1206401A/en not_active Expired
- 1983-06-09 ES ES523127A patent/ES8402877A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DE3362076D1 (en) | 1986-03-20 |
| ZA834166B (en) | 1984-03-28 |
| IE831351L (en) | 1983-12-09 |
| ATE17872T1 (de) | 1986-02-15 |
| ES523127A0 (es) | 1984-03-16 |
| DD209848A5 (de) | 1984-05-23 |
| CA1206401A (en) | 1986-06-24 |
| ES8402877A1 (es) | 1984-03-16 |
| IE55265B1 (en) | 1990-07-18 |
| DE3221730A1 (de) | 1983-12-15 |
| JPH0368679B2 (cg-RX-API-DMAC7.html) | 1991-10-29 |
| US4591553A (en) | 1986-05-27 |
| EP0100413B1 (de) | 1986-02-05 |
| EP0100413A1 (de) | 1984-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2052819C1 (ru) | Способ определения электрононасыщенного ароматического амина, являющегося маркером содержания аналита в биологической жидкости, и средство для его осуществления | |
| CA1155737A (en) | Process and diagnostic agents for the detection of redox reactions | |
| Paoletti et al. | A sensitive spectrophotometric method for the determination of superoxide dismutase activity in tissue extracts | |
| EP0103901B1 (en) | Multilayer analytical element | |
| JPS62157554A (ja) | 試料成分の濃度を測定するための試験具及び試験方法 | |
| JPS603835B2 (ja) | トリンダ−試薬、及びそれを使用して過酸化水素を分析する方法 | |
| JPH0687793B2 (ja) | 酵素酸化によるアナライトの比色定量方法および試剤、およびそのための還元発色性電子受容体 | |
| JPS6129462B2 (cg-RX-API-DMAC7.html) | ||
| JPH0470000B2 (cg-RX-API-DMAC7.html) | ||
| Morin et al. | Single Glucose Oxidase—Peroxidase reagent for two-minute determination of serum glucose | |
| US3630847A (en) | Diagnostic agent for use in the determination of hydroperoxides and of peroxidate-active substances | |
| EP0122641A2 (en) | Analytical reagent, analytical method, and multilayer chemical-analytical element | |
| JPS5819279B2 (ja) | Ｎａｄ（ｐ）ｈ又はサリチル酸塩を測定する方法及び試薬 | |
| US5055388A (en) | Process and reagent composition for determination of fructosamine in body fluids | |
| US4271265A (en) | Method and reagent for the determination of glutamate-oxalacetate transaminase and glutamate-pyruvate transaminase | |
| US5610025A (en) | Inhibition of interfering endogenous enzyme activity in assays of biological fluids | |
| JPH0332360B2 (cg-RX-API-DMAC7.html) | ||
| JPS58220696A (ja) | グルタメ−ト−オキサロアセテ−ト−トランスアミナ−ゼの活性測定法及びそのための分析試薬及び分析試験片 | |
| EP0926244B1 (en) | Methods and reagents for quantitatively determining ascorbic acid | |
| JPH0369520B2 (cg-RX-API-DMAC7.html) | ||
| US5106753A (en) | Method for determining manganese level in blood using a porphyrin composition | |
| US3778384A (en) | Diagnostic composition for the quantitative determination of glucose | |
| JPS6259782B2 (cg-RX-API-DMAC7.html) | ||
| Chubb et al. | An enzyme mediated, colorimetric method for the measurement of salicylate | |
| JPS5818077B2 (ja) | グリセリンを測定する方法及び試薬 |